These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35482550)

  • 1. ALLSorts: an RNA-Seq subtype classifier for B-cell acute lymphoblastic leukemia.
    Schmidt B; Brown LM; Ryland GL; Lonsdale A; Kosasih HJ; Ludlow LE; Majewski IJ; Blombery P; Ekert PG; Davidson NM; Oshlack A
    Blood Adv; 2022 Jul; 6(14):4093-4097. PubMed ID: 35482550
    [No Abstract]   [Full Text] [Related]  

  • 2. [Morphometric and electrokinetic criteria of cell identification in acute lymphoblastic leukemia].
    Muskhelishvili LV
    Gematol Transfuziol; 1990 Nov; 35(11):20-2. PubMed ID: 2283021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of monoclonal antibodies in acute lymphoblastic leukemia in children. I. Immunological subclassification of acute lymphoblastic leukemia].
    Kołecki P; Radwańska U
    Pediatr Pol; 1988 Nov; 63(11):693-7. PubMed ID: 3253655
    [No Abstract]   [Full Text] [Related]  

  • 4. Aneuploidy in childhood B cell acute lymphoblastic leukaemia - also a relevant prognostic factor in relapsed disease?
    Zugmaier G
    Br J Haematol; 2019 Mar; 184(6):895-896. PubMed ID: 30723892
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia.
    Escherich C; Chen W; Miyamoto S; Namikawa Y; Yang W; Teachey DT; Li Z; Raetz EA; Larsen E; Devidas M; Martin PL; Bowman WP; Wu G; Pui CH; Hunger SP; Loh ML; Takagi M; Yang JJ
    Blood Adv; 2023 May; 7(10):2177-2180. PubMed ID: 36576946
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia.
    Desikan SP; Senapati J; Jabbour E; Abuasab T; Short N; Tang G; Wang S; Kebriaei P; Kadia T; Borthakur G; Ravandi F; Roberts K; Mullighan C; Konopleva M; Kantarjian H; Jain N
    Am J Hematol; 2023 Jun; 98(6):E142-E144. PubMed ID: 36877196
    [No Abstract]   [Full Text] [Related]  

  • 7. CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia.
    van Zutven LJ; van Drunen E; de Bont JM; Wattel MM; Den Boer ML; Pieters R; Hagemeijer A; Slater RM; Beverloo HB
    Leukemia; 2005 Jul; 19(7):1281-4. PubMed ID: 15843818
    [No Abstract]   [Full Text] [Related]  

  • 8. Practical Considerations for Using RNA Sequencing in Management of B-Lymphoblastic Leukemia: Malaysia-Singapore Acute Lymphoblastic Leukemia 2020 Implementation Strategy.
    Ni Chin WH; Li Z; Jiang N; Lim EH; Suang Lim JY; Lu Y; Chiew KH; Yin Kham SK; Zhi Oh BL; Tan AM; Ariffin H; Yang JJ; Eng-Juh Yeoh A
    J Mol Diagn; 2021 Oct; 23(10):1359-1372. PubMed ID: 34365011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of Rare Gene Alterations in the Prognosis of B-Cell Acute Lymphoblastic Leukemia.
    Xiang L; Wang Y; Pan W
    Turk J Haematol; 2024 Mar; 41(1):49-50. PubMed ID: 38174667
    [No Abstract]   [Full Text] [Related]  

  • 10. Philadelphia positive acute lymphoblastic leukemia 16 years after the apparent cure of acute lymphoblastic leukemia. New leukemia or late relapse?
    Navarro JL; de Blas Orlando J; Ríos Herranz E; González Campos J; Parody R; Rodríguez Fernández JM
    Haematologica; 1998 Sep; 83(9):855-6. PubMed ID: 9825584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemia.
    Zaliova M; Potuckova E; Lukes J; Winkowska L; Starkova J; Janotova I; Sramkova L; Stary J; Zuna J; Stanulla M; Zimmermann M; Bornhauser B; Bourquin JP; Eckert C; Cario G; Trka J
    Haematologica; 2021 Mar; 106(3):886-890. PubMed ID: 32499245
    [No Abstract]   [Full Text] [Related]  

  • 12. Amplification of the
    Ray D; Sharma P; Jain A; Sreedharanunni S
    Turk J Haematol; 2023 Aug; 40(3):204-205. PubMed ID: 37649438
    [No Abstract]   [Full Text] [Related]  

  • 13. RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia.
    Kubota H; Ueno H; Tasaka K; Isobe T; Saida S; Kato I; Umeda K; Hiwatari M; Hasegawa D; Imamura T; Kakiuchi N; Nannya Y; Ogawa S; Hiramatsu H; Takita J
    Blood Adv; 2024 Mar; 8(5):1258-1271. PubMed ID: 38127276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia.
    Leongamornlert D; Gutiérrez-Abril J; Lee S; Barretta E; Creasey T; Gundem G; Levine MF; Arango-Ossa JE; Liosis K; Medina-Martinez JS; Zuborne Alapi K; Kirkwood AA; Clifton-Hadley L; Patrick P; Jones D; O'Neill L; Butler AP; Harrison CJ; Campbell P; Patel B; Moorman AV; Fielding AK; Papaemmanuil E
    Blood Adv; 2023 Aug; 7(15):3862-3873. PubMed ID: 36867579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of CRLF2 overexpression and JAK2 mutation in Egyptian pediatric patients with B-precursor acute lymphoblastic leukemia.
    Hassan NM; Abdellateif MS; Radwan EM; Hameed SA; Desouky EDE; Kamel MM; Gameel AM
    Clin Lymphoma Myeloma Leuk; 2022 Jun; 22(6):e376-e385. PubMed ID: 34987014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barre syndrome as a paraneoplastic phenomenon in a child with MYC rearranged B-cell acute lymphoblastic leukemia.
    Cooksey R; Kubaney H; Loudamy L; Mitchell M; Cohn S
    Pediatr Blood Cancer; 2024 Apr; 71(4):e30886. PubMed ID: 38289008
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcome and molecular measurable residual disease monitoring in adult B-cell acute lymphoblastic leukemia patients with MEF2D fusions.
    Sun K; Chen WM; Wang X; Zhao XS; Li LD; Hao Y; Wang J; Xu N; Jiang Q; Jiang H; Xu LP; Wang Y; Zhang XH; Huang XJ; Qin YZ
    Hematol Oncol; 2023 Aug; 41(3):594-597. PubMed ID: 36516881
    [No Abstract]   [Full Text] [Related]  

  • 18. Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis.
    Podgorica M; Drivet E; Viken JK; Richman A; Vestbøstad J; Szodoray P; Kvam AK; Wik HS; Tjønnfjord GE; Munthe LA; Frietze S; Schjerven H
    Eur J Haematol; 2024 May; 112(5):731-742. PubMed ID: 38192186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined analysis of
    Cui L; Gao C; Wang CJ; Zhao XX; Li WJ; Li ZG; Zheng HY; Wang TY; Zhang RD
    Leuk Lymphoma; 2021 Feb; 62(2):410-418. PubMed ID: 33054468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic Leukemia.
    Shiraz P; Payne KJ; Muffly L
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32235787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.